Research Article

The Coronary Angiography-Derived Index of Microcirculatory Resistance Predicts Left Ventricular Performance Recovery in Patients with ST-Segment Elevation Myocardial Infarction

Table 1

Clinical, angiographic, and procedural characteristics.

VariableTotal (n = 80)

Demographics
 Age (y)58.0 ± 12.7
 Male64 (80.0%)
 Body mass index (kg/m2)24.7 ± 3.3
Cardiovascular risk factors
 Hypertension50 (62.5%)
 Diabetes26 (32.5%)
 Hyperlipidemia39 (48.8%)
 Chronic kidney disease4 (5.0%)
 Current smoking47 (58.8%)
Previous PCI7 (8.8%)
Previous CABG1 (1.3%)
Hemodynamic parameters
 Systolic blood pressure (mmHg)125.5 ± 19.4
 Diastolic blood pressure (mmHg)72.7 ± 10.4
Cardiac function (Killip class)
 I65 (81.3%)
 II8 (10.0%)
 III1 (1.3%)
 IV6 (7.5%)
Culprit vessel
 Left anterior descending51 (63.7%)
 Left circumflex8 (10.0%)
 Right coronary artery21 (26.3%)
Multivessel disease61 (76.3%)
Symptom onset-to-balloon time (h)7 (3.5–21.875)
Thrombus aspiration7 (8.8%)
Glycoprotein IIb/IIIa inhibitor use8 (10.0%)
Adjunctive balloon dilatation5 (6.3%)
Total number of stents1 (1-2)
Mean stent diameter (mm)3.0 (2.75–3.5)
Total length of stents (mm)32 (24–46)
Post-PCI TIMI flow grade
 26 (7.5%)
 374 (92.5%)
Coronary physiological measurements
 cTFC22.98 ± 13.00
 caFFR0.93 (0.89–0.94)
 caIMR43.2 ± 16.1
Laboratory profiles
 Peak troponin I (ng/ml)19742.35 (81.00–74380.48)
 Peak CK-MB (ng/ml)180.79 (56.02–238.48)
 C-reactive protein (mg/L)8.8 (1.0–30.3)
 Low-density lipoprotein cholesterol (mmol/L)2.88 ± 0.87
 Estimated glomerular filtration rate (ml/min1.73 m2)87.4 ± 20.6
Discharge medication
 Aspirin80 (100%)
 P2Y12 inhibitor80 (100%)
 Statins80 (100%)
 Beta-blocker66 (82.5%)
 ACEI/ARB60 (75.0%)

PCI, percutaneous coronary intervention; CABG, coronary artery bypass graft; TIMI, thrombolysis in myocardial infarction; cTFC, corrected thrombolysis in myocardial infarction frame count; caFFR, coronary angiography-derived fractional flow reserve; caIMR, coronary angiography-derived index of microcirculatory resistance; ACEI, angiotensin converting enzyme inhibitor; ARB, angiotensin receptor blocker.